A new study shows that while free medication programs offered by the pharmaceutical industry help some low-income patients without drug coverage, health care providers report substantial barriers for patients who could otherwise benefit from these programs.
The study, which will be published in the April 1 issue of the American Journal of Health-System Pharmacy, surveyed "safety net" providers serving primarily low-income patients. Funded by the California HealthCare Foundation and conducted by researchers independent of the drug industry, the study comes shortly after the California launch of a $10 million effort by the Pharmaceutical Research and Manufacturers of America (PhRMA) to promote its charitable programs. PhRMA will announce a similar national effort on April 5.
Read more from this post.
